Product Name: Kallikrein 13 antibody
Applications: WB
Predicted Target Size:
Positive Controls:
Form Supplied: Liquid
Concentration: 1 mg/ml (Please refer to the vial label for the specific concentration)
Purification: Affinity purified
Full Name: kallikrein-related peptidase 13
Background: Kallikreins are a subgroup of serine proteases and are implicated in carcinogenesis. The novel KLK gene, KLK-L4, is expressed in a variety of tissues including prostate, salivary gland, breast, and testis. Its expression is regulated by steroid hormones in breast cancer cell lines may be involved in the pathogenesis and/or progression of breast cancer.
Synonyms: DKFZp586J1923, KLK-L4, KLKL4, KLK L4
Cellular Localization:
CAS NO: 713492-66-1
Product: Quinacrine (dihydrochloride)
Host: Rabbit
Clonality: Polyclonal
Isotype: IgG
Immunogen: Residues 262-277 [IRKYETQQQKWLKGPQ] of the human Kallikrein 13 protein.
Antigen Species: Human
Species Reactivity: Human
Conjugation: Unconjugated
Storage Buffer: PBS with 0.02% sodium azide
Storage Instruction: Keep as concentrated solution. Store at 4ºC short term. For extended storage aliquot and store at -20ºC or below. Avoid freeze-thaw cycles.
Notes: For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Specificity: Reacts with residues 262-277 [IRKYETQQQKWLKGPQ] of the human Kallikrein 13 protein.
PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/12533527?dopt=Abstract
